Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

venBio Partners
San FranciscoSeed–Late Stage
11 people
aMoon
Ra'ananaSeed–Late Stage
19 people
DAYLI Partners
SeoulSeed–Late Stage
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
30 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Cenova Capital
ShanghaiSeries A–Late Stage
22 people
Signet Healthcare Partners
New YorkGrowth–Late Stage$10M – $50M
13 people
TCG Crossover
Palo AltoSeed–Late Stage
25 people
VenturEast
BangaloreSeed–Late Stage
14 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
European Circular Bioeconomy Fund
BonnSeries A–Late Stage$5.5M – $16.5M
23 people
Sanderling Ventures
San MateoSeed–Late Stage$50K – $1M
8 people
Beyond Earth Ventures
WilmingtonPre-Seed–Late Stage$500K – $2M
16 people
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
12 people
Spring Activator
VancouverPre-Seed–Late Stage
33 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Funds Startups
TokyoSeed–Late Stage$66M
24 people
Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
27 people
PortfoLion Capital Partners
BudapestSeed–Late Stage$540K – $32.4M
33 people
Pangaea Ventures Us Inc.
VancouverSeed–Late Stage$500K – $1.5M
13 people
Pontifax Venture Capital
HerzeliyaPre-Seed–Late Stage$6.3M – $128M
9 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
26 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.